Skye BioscienceSKYE
13F holders, Q1 2026 (March 31)39holders −11
1new positions
14sold out
1famous investor
$0.61avg. 13F price*
At the end of Q1 2026, 39 institutions reported holding Skye Bioscience Inc. (SKYE) in their 13F filings, down 11 from Q4 2025. 1 opened new positions and 14 sold out. The largest holders were 5AM Venture Management, LLC ($6.0M), Versant Venture Management, LLC ($1.2M) and Baker Bros. Advisors LP ($968K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Skye Bioscience Inc.
- CUSIP
- 83086J200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1 |
| Exits | 14 | $150K |
All 13F filers, Q4 2025 → Q1 2026: 429,134 shares bought and 380,355 shares sold, net +48,779 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| 5AM Venture Management, LLC | 1.65% | No change | 9,681,763 | $6.0M |
| Versant Venture Management, LLC | 0.87% | No change | 2,007,704 | $1.2M |
| Baker Bros. Advisors LP | 0.01% | Add +8.6% | 1,575,243 | $968K |
| Vanguard Capital Management LLC | 0.00% | — | 764,457 | $470K |
| Sphera Funds Management LTD. | 0.07% | Add +41.8% | 678,928 | $417K |
| BlackRock, Inc. | 0.00% | Add +1.5% | 286,131 | $176K |
| Geode Capital Management, LLC | 0.00% | Add +31.9% | 277,256 | $170K |
| Millennium Management | 0.00% | Reduce -32.1% | 258,200 | $159K |
| Platinum Investment Management Ltd. | 0.04% | No change | 233,095 | $143K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 104,229 | $64K |
| State Street Corp. | 0.00% | No change | 75,326 | $46K |
| UBS Group AG | 0.00% | Add +244.4% | 45,762 | $28K |
| XTX Topco Ltd | 0.00% | Reduce -22.9% | 40,919 | $25K |
| Two Sigma Investments, LP | 0.00% | Reduce -50.3% | 25,684 | $16K |
| Engineers Gate Manager LP | 0.00% | Reduce -12.7% | 20,194 | $12K |
| Northern Trust Corp. | 0.00% | No change | 20,142 | $12K |
| Barclays PLC | 0.00% | Reduce -14.9% | 18,089 | $11K |
| Group One Trading LLC | 0.00% | Reduce -59.3% | 7,205 | $4K |
| Vanguard Global Advisers, LLC | 0.00% | — | 4,557 | $3K |
| Morgan Stanley | 0.00% | Reduce -40.3% | 2,549 | $2K |
| Federated Hermes, Inc. | 0.00% | No change | 1,158 | $712 |
| Osaic Holdings, Inc. | 0.00% | Add +29900.0% | 600 | $364 |
| National Bank of Canada | 0.00% | No change | 400 | $242 |
| TD Waterhouse Canada Inc. | 0.00% | Add +216.0% | 79 | $51 |
| JPMorgan Chase & Co. | 0.00% | No change | 66 | $39 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | No change | 52 | $32 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 51 | $31 |
| Rockefeller Capital Management L.P. | 0.00% | No change | 39 | $24 |
| Optiver Holding B.V. | 0.00% | No change | 20 | $12 |
| CoreCap Advisors, LLC | 0.00% | No change | 8 | $5 |
| Plante Moran Financial Advisors, LLC | 0.00% | No change | 3 | $2 |
| Harbour Investments, Inc. | 0.00% | No change | 1 | $1 |
| Citigroup Inc. | 0.00% | New | 2 | $1 |
| IFP Advisors, Inc | 0.00% | Add +100.0% | 2 | $1 |
| NFSG Corp | 0.00% | Reduce -94.4% | 1 | $1 |
| Leo H. Evart, Inc. | 0.00% | — | 1 | $1 |
| PFS Partners, LLC | 0.00% | No change | 1 | $1 |
| McGuire Capital Advisors Inc. | 0.00% | No change | 2 | $1 |
| Royal Bank of Canada | 0.00% | Add +2.4% | 127 | $0 |
"% of holder's portfolio" is SKYE's weight in each manager's 13F, not the share of Skye Bioscience Inc. the manager owns.